Physician
Optumcare New Mexico LLC
Optumcare New Mexico LLC was paid $23.64M by Medicaid between Jan 2018 and Dec 2024, across 193 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoOPTUMCARE NEW MEXICO LLC
ALBUQUERQUE, NM 87106
ALBUQUERQUE, NM 87106
33aNPI1124053210assigned 07/11/2006
33bProvider typeFamily Medicine Physician
28Total paid$23.64M
24GClaims410,561
24DCodes billed193
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New Mexico
Rank by total paid#4 of 148
Median peer was paid$167K
This provider vs. median141×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CASTILLO, EMILY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 76,238 | $3.95M | |
| 2019 | 79,575 | $4.43M | |
| 2020 | 48,968 | $2.63M | |
| 2021 | 61,832 | $3.33M | |
| 2022 | 60,407 | $3.48M | |
| 2023 | 58,732 | $3.67M | |
| 2024incomplete | 24,809 | $2.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 78,783 | 74,572 | $6.47M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 58,195 | 55,148 | $4.04M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.3% | 33,006 | 32,739 | $1.72M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.5% | 13,372 | 13,306 | $1.54M |
| 90461 | 6.2% | 17,117 | 16,996 | $1.46M | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.9% | 12,113 | 12,061 | $1.40M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.3% | 11,057 | 10,292 | $1.25M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.9% | 8,084 | 8,043 | $928K |
| 99173 | 3.2% | 19,780 | 19,682 | $759K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.8% | 24,487 | 24,307 | $428K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1.1% | 149 | 135 | $269K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,159 | 1,953 | $205K |
181 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,170 | $199K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 259 | $182K |
| 90677 | <1% | 573 | $169K | |
| 20610 | <1% | 3,316 | $136K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,396 | $119K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,037 | $115K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,399 | $109K |
| 62323 | <1% | 1,026 | $107K | |
| 99177 | <1% | 3,097 | $106K | |
| 95913 | <1% | 521 | $94K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,791 | $82K |
| 76000 | <1% | 2,530 | $79K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,228 | $69K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 497 | $69K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,838 | $67K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 469 | $61K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 628 | $55K |
| 95886 | <1% | 545 | $53K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,855 | $53K |
| 92551 | <1% | 4,295 | $51K | |
| J0178 | Injection, aflibercept, 1 mg | <1% | 96 | $50K |
| 73564 | <1% | 2,153 | $48K | |
| 99188 | <1% | 2,541 | $48K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 418 | $41K |
| 96127 | <1% | 6,782 | $38K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,890 | $38K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 673 | $35K |
| 76830 | Ultrasound, transvaginal | <1% | 622 | $33K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,110 | $30K |
| 90674 | <1% | 1,093 | $26K | |
| 99381 | <1% | 143 | $26K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,636 | $24K |
| 73630 | <1% | 1,267 | $24K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 615 | $23K |
| 76942 | <1% | 781 | $23K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 358 | $23K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 216 | $23K |
| 73030 | <1% | 1,593 | $22K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 465 | $22K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 365 | $21K |
| 20550 | <1% | 400 | $21K | |
| 64615 | <1% | 249 | $20K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 270 | $17K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 2,241 | $16K |
| 90756 | <1% | 624 | $16K | |
| 73221 | <1% | 124 | $15K | |
| 92134 | <1% | 883 | $15K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,319 | $14K |
| 31231 | <1% | 100 | $14K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 723 | $14K |
| 99383 | <1% | 68 | $13K | |
| 0012A | <1% | 366 | $13K | |
| 73130 | <1% | 739 | $13K | |
| 73610 | <1% | 729 | $13K | |
| 73110 | <1% | 720 | $12K | |
| 90671 | <1% | 43 | $12K | |
| 64493 | <1% | 81 | $12K | |
| 90619 | <1% | 88 | $12K | |
| 73502 | <1% | 537 | $10K | |
| 62321 | <1% | 88 | $10K | |
| 72141 | <1% | 96 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 529 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 160 | $9K |
| 97802 | <1% | 190 | $9K | |
| 93000 | <1% | 1,132 | $8K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,118 | $8K |
| 76536 | <1% | 196 | $8K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 51 | $7K |
| 81025 | <1% | 935 | $7K | |
| 72110 | <1% | 286 | $7K | |
| 76642 | <1% | 116 | $7K | |
| 93970 | <1% | 58 | $7K | |
| 99441 | <1% | 299 | $7K | |
| 90734 | <1% | 1,990 | $7K | |
| 94060 | <1% | 261 | $6K | |
| 93793 | <1% | 894 | $6K | |
| 90651 | <1% | 2,998 | $6K | |
| 97803 | <1% | 211 | $6K | |
| 20553 | <1% | 171 | $6K | |
| 90698 | <1% | 6,428 | $6K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 30 | $6K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 127 | $6K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $6K |
| 93971 | <1% | 65 | $5K | |
| 99384 | <1% | 26 | $5K | |
| 99051 | <1% | 572 | $4K | |
| 94729 | <1% | 188 | $4K | |
| 64494 | <1% | 62 | $4K | |
| 92557 | <1% | 176 | $4K | |
| 0011A | <1% | 208 | $4K | |
| 71250 | <1% | 68 | $4K | |
| 99201 | <1% | 99 | $4K | |
| 96161 | <1% | 774 | $4K | |
| 73080 | <1% | 210 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 39 | $3K |
| 90473 | <1% | 144 | $3K | |
| 99205 | Prolong outpt/office vis | <1% | 16 | $3K |
| 94726 | <1% | 127 | $3K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 84 | $3K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $3K |
| 72050 | <1% | 148 | $3K | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | <1% | 23 | $3K |
| 98966 | <1% | 309 | $3K | |
| 74018 | <1% | 153 | $3K | |
| 92567 | <1% | 278 | $3K | |
| 77080 | <1% | 108 | $2K | |
| 99443 | <1% | 38 | $2K | |
| 72120 | <1% | 110 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 28 | $2K |
| 90710 | <1% | 430 | $2K | |
| 87807 | <1% | 126 | $2K | |
| 10060 | <1% | 53 | $2K | |
| 20552 | <1% | 46 | $2K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 17 | $2K |
| 90686 | <1% | 11,087 | $2K | |
| 73562 | <1% | 79 | $2K | |
| 90680 | <1% | 3,279 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 14 | $2K |
| 72100 | <1% | 95 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 12 | $2K |
| 0111A | <1% | 35 | $1K | |
| 99442 | <1% | 27 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 158 | $1K |
| 85610 | <1% | 327 | $1K | |
| 90633 | <1% | 2,734 | $1K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 75 | $1K |
| 92015 | Determination of refractive state | <1% | 212 | $1K |
| 73140 | <1% | 79 | $1K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 30 | $1K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 53 | $1K |
| 90661 | <1% | 41 | $1K | |
| 99221 | <1% | 13 | $1K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 47 | $1K |
| 90620 | <1% | 115 | $973.82 | |
| 77071 | <1% | 47 | $971.38 | |
| 90474 | <1% | 34 | $832.82 | |
| 90696 | <1% | 404 | $621.61 | |
| 90744 | <1% | 1,392 | $620.45 | |
| D1206 | Topical application of fluoride varnish | <1% | 42 | $603.00 |
| 90715 | <1% | 644 | $526.45 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 33 | $331.02 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 14 | $309.89 |
| G0008 | Administration of influenza virus vaccine | <1% | 29 | $295.23 |
| 17000 | <1% | 13 | $290.73 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 37 | $255.48 |
| 76857 | <1% | 14 | $254.59 | |
| 90670 | <1% | 6,432 | $220.49 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 610 | $217.82 |
| 90707 | <1% | 176 | $169.25 | |
| 73560 | <1% | 12 | $159.11 | |
| 72040 | <1% | 12 | $145.09 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 63 | $107.83 |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 29 | $101.80 |
| 90716 | <1% | 176 | $100.56 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 254 | $71.05 |
| 94760 | <1% | 371 | $69.18 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 38 | $55.19 |
| 81003 | <1% | 16 | $20.91 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 18 | $0.77 |
| 91301 | <1% | 121 | $0.58 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 53 | $0.15 |
| 91311 | <1% | 65 | $0.14 | |
| 90672 | <1% | 361 | $0.01 | |
| 3078F | 0% | 989 | $0.00 | |
| 1160F | 0% | 752 | $0.00 | |
| 90685 | 0% | 834 | $0.00 | |
| 90621 | 0% | 88 | $0.00 | |
| 1159F | 0% | 630 | $0.00 | |
| 3077F | 0% | 47 | $0.00 | |
| 90648 | 0% | 66 | $0.00 | |
| 3079F | 0% | 420 | $0.00 | |
| 3074F | 0% | 368 | $0.00 | |
| 3073F | 0% | 888 | $0.00 | |
| 1125F | 0% | 421 | $0.00 | |
| 3008F | 0% | 249 | $0.00 | |
| 1126F | 0% | 457 | $0.00 | |
| 3075F | 0% | 98 | $0.00 | |
| 90723 | 0% | 134 | $0.00 | |
| 3080F | 0% | 44 | $0.00 | |
| 90656 | 0% | 19 | $0.00 | |
| 90647 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCASTILLO, EMILY (ASSOCIATE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Southwest Medical Associates, INC | Las Vegas, NV | $15.80M |
| Optumcare Colorado Medical Group LLC | Colorado Springs, CO | $8.74M |
| The Corvallis Clinic P C | Corvallis, OR | $8.06M |
| Optum Medical Group II Rhodes P C | Las Vegas, NV | $6.70M |
| Sierra Home Medical Products INC | Las Vegas, NV | $6.20M |
| Southwest Medical Associates INC. | Las Vegas, NV | $5.20M |
| Optum Medical Group Rhodes P C | Las Vegas, NV | $4.43M |
| Family Health Care Services, INC | Las Vegas, NV | $4.39M |
| 4C Medical Group PLC | Scottsdale, AZ | $4.28M |
| Greater Phoenix Collaborative Care PC | Phoenix, AZ | $3.18M |
| Beaver Medical Group P C | Redlands, CA | $2.88M |
| Sierra Home Medical Products, INC | Las Vegas, NV | $2.40M |
| Centers for Family Medicine GP | Los Alamitos, CA | $2.39M |
| Optum Medical Group II Rhodes P C | Las Vegas, NV | $1.77M |
| Family Home Hospice, INC. | Las Vegas, NV | $1.42M |
| Surprise Health Center, PLLC | Surprise, AZ | $1.20M |
| Doc Martins INC a C C | Flagstaff, AZ | $1.08M |
| New West Physicians INC | Golden, CO | $970K |
| Southwest Medical Associates, INC | Las Vegas, NV | $612K |
| Warner Family Practice, PC | Chandler, AZ | $207K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.